Academic Journal
Q1European Heart Journal
About European Heart Journal
European Heart Journal is a scholarly journal published by Oxford University Press. SCImago 2025 places it in Q1 with an SJR of 5.326 and an H-index of 385.
Its listed coverage is 1980-2026 and its research categories include Cardiology and Cardiovascular Medicine (Q1). The 2025 dataset reports 855 documents and 21131 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors, Atrial Fibrillation Management and Outcomes, Cardiac Valve Diseases and Treatments, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics.
Recent Research Articles
Latest publications matched automatically by ISSN.
Correction to: Quadruple vs triple therapy for resistant hypertension: the QUADRO trial
2026-09-08 · DOI: 10.1093/eurheartj/ehag758High-dimensional adaptive immune cell patterns in coronary artery disease patients predict cardiovascular outcome
Jill de Mol, Marie Depuydt, Bram Slütter
2026-09-07 · DOI: 10.1093/eurheartj/ehag675Reconciling evidence-based and personalized medicine: perspectives in heart failure and cardiomyopathies
Gherardo Finocchiaro, Maria Perotto, Marco Merlo, Thomas F Lüscher et al.
2026-09-07 · DOI: 10.1093/eurheartj/ehag596From risk enrichment to clinical utility: next steps for peri-aortic cardiovascular age
Mendel Lebowitz, Gourav Modanwal, Anant Madabhushi
2026-09-07 · DOI: 10.1093/eurheartj/ehag689Subclinical liver disease and incident cardiovascular events
Le Li, Lingmin Wu, Zhicheng Hu, Limin Liu et al.
2026-09-07 · DOI: 10.1093/eurheartj/ehag700Quality standards for preclinical research in cardio-oncology
Pietro Ameri, Rosalinda Madonna, Ambra Costa, Uri Amit et al.
2026-09-07 · DOI: 10.1093/eurheartj/ehag609When partial benefits overshadow the global harm: alcohol, cardiovascular risk, and the net population balance
Francisco Rivas Ruiz, Rafael Bravo Marqués
2026-09-07 · DOI: 10.1093/eurheartj/ehag695When the exposure causes selection bias: understanding why risk factors attenuate in secondary as compared with primary prevention and what to do about it
Nicholas H Adamstein, Paul M Ridker
2026-09-07 · DOI: 10.1093/eurheartj/ehag725Novel oblique dynamic chest radiography for retrocardiac pulmonary blood flow imaging in chronic thromboembolic pulmonary hypertension
Tasuku Namajima, Ryuichi Ushijima, Rie Tanaka
2026-09-07 · DOI: 10.1093/eurheartj/ehag711More is not always better: vitamin D supplementation post-myocardial infarction in the Target-D trial
John W Davis, JoAnn E Manson
2026-09-07 · DOI: 10.1093/eurheartj/ehag672Beyond alcohol: reassessing wine in the context of the Mediterranean diet and drinking patterns
Miguel A Martínez-González, Maira Bes-Rastrollo, Ramón Estruch
2026-09-07 · DOI: 10.1093/eurheartj/ehag696Epicardial induced pluripotent stem cell–cardiomyocyte patch therapy: the vascularization challenge
Yueheng Wu
2026-09-07 · DOI: 10.1093/eurheartj/ehag717Peri-aortic radiomic cardiovascular age: net benefit and intervenability
Yu Xiao
2026-09-07 · DOI: 10.1093/eurheartj/ehag687Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial
Heidi T May, Viet T Le, Jeffrey L Anderson, Leslie Iverson et al.
2026-09-07 · DOI: 10.1093/eurheartj/ehag611Progressive QRS widening preceding delayed malignant ventricular arrhythmias after pulsed field ablation
Kazuya Nakagawa, Kenji Kuroki, Kazutaka Aonuma
2026-09-03 · DOI: 10.1093/eurheartj/ehag692Ischaemic stroke in atrial flutter vs fibrillation: a Finnish nationwide study
Hermon Eyob Fesseha, Aapo L Aro, Konsta Teppo, Jari Haukka et al.
2026-09-03 · DOI: 10.1093/eurheartj/ehag681Aortic dissection due to calcified plaque rupture
Xiaolang Jiang, Zhihui Dong, Weiguo Fu
2026-09-03 · DOI: 10.1093/eurheartj/ehag669Weekly Journal Scan: A novel electrocardiogram biomarker predicting sudden cardiac death: ready for prime time?
Gaetano Antonio Lanza, Giovanna Liuzzo
2026-09-03 · DOI: 10.1093/eurheartj/ehag682Shaping platelet inhibition in women: the role of the P2Y12 receptor
Giovanni Occhipinti, Claudio Laudani, Mattia Galli
2026-09-03 · DOI: 10.1093/eurheartj/ehag665Angiotensin II-driven TGF-β1 increases platelet PAR4 expression enhancing thrombotic risk in hypertension
Mingzhu Wang, Zixian Liu, Yufei Chen, Shufang Wang et al.
2026-09-03 · DOI: 10.1093/eurheartj/ehag632Reviews
Community Reviews
Version History
September 7, 2026 at 11:59 pm
September 7, 2026